Skip to content

The effect of compassion-focused therapy on self-compassion, self-esteem, and resiliency of women victims of spousal abuse

The effect of compassion-focused therapy on self-compassion, self-esteem, and resiliency of women victims of spousal abuse.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250718066539N1
Enrollment
60
Registered
2026-03-09
Start date
2025-10-12
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intimate partner violence.

Interventions

Intervention 1: Intervention group: It Includes 30 women. Compassion-Focused Therapy based on Paul Gilbert's approach will be held for 8 weekly 90-minute sessions for the intervention group. Intervent

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Having Iranian nationality Being married with a permanent marriage Aged between 18 and 55 years Having lived together for at least one year Having experienced domestic violence by the husband at least during the past year (based on the CTS2 questionnaire) Ability to understand and speak Persian, having a minimum education level of high school diploma or higher (due to the ability to understand intervention-related concepts and complete assignments) Not being pregnant or in the postpartum period (up to six months after delivery) No simultaneous participation in a similar intervention Not filing for divorce No experience of severe stressors such as divorce, accidents, or bereavement of relatives in the past six months Scoring below 68 on the Neff Self-Compassion Scale

Exclusion criteria

Exclusion criteria: Use of psychotropic drugs, including anti-anxiety medications (such as clonazepam, alprazolam, lorazepam), antidepressants (such as fluoxetine, paroxetine, sertraline), antipsychotics (such as chlorpromazine, fluphenazine, haloperidol), mood stabilizers (such as lithium, carbamazepine, sodium valproate), and stimulants (such as amphetamine, dexmethylphenidate, dextroamphetamine) within 6 months prior to participation in the study and during the study. History of hospitalization in a psychiatric or neurology ward Suffering from any underlying and incurable diseases such as cancer or malignant tumors History of alcohol or drug abuse in the participant or their spouse Having impaired consciousness

Design outcomes

Primary

MeasureTime frame
Women whose Neff Self-Compassion Scale score is less than 68. Timepoint: Before the start of the intervention, immediately after the end of the intervention, and two months after the end of the intervention. Method of measurement: Neff Self-Compassion Scale.;Self-Esteem score on the Rosenberg Scale. Timepoint: Before the start of the intervention, immediately after the end of the intervention, and two months after the end of the intervention. Method of measurement: Rosenberg Self-Esteem Scale.;Resilience score in the Connor and Davidson Scale. Timepoint: Before the start of the intervention, immediately after the end of the intervention, and two months after the end of the intervention. Method of measurement: Connor and Davidson Resilience Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Khavari

Arak University of Medical Sciences

tkhavari1376@gmail.com+98 25 3725 4604

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026